SheerVision, Inc. (SVSO) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 15, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerSheerVision, Inc. (SVSO) trades at $0.0002. SheerVision, Inc. designs, develops, and manufactures specialized loupe and headlight systems for surgical, dental, dental hygiene, and veterinary markets. Sector: Healthcare.
Price as of · Last analyzed: Jun 15, 2026Analyst Coverage for SVSO: SVSO does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
SheerVision, Inc. (SVSO) Healthcare & Pipeline Overview
SheerVision, Inc. specializes in the design and manufacturing of advanced loupe and headlight systems, serving critical surgical, dental, and veterinary markets. Established in 1999, the company provides specialized visualization tools, including flip-up and through-the-lens systems, distributed via e-commerce and a network of partners, positioning it within the specialized medical instruments sector.
What Is the Investment Thesis for SVSO?
SheerVision, Inc. operates within the specialized medical instruments sector, focusing on essential loupe and headlight systems for surgical, dental, and veterinary professionals. The company exhibits a strong gross margin of 62.2%, indicating efficient cost management relative to its revenue from product sales. This high margin suggests a premium value proposition for its specialized visualization tools. However, the company currently reports a negative profit margin of -2.0%, signaling operational unprofitability that warrants close investor scrutiny regarding cost structures and revenue scalability. Key growth catalysts for SheerVision include the ongoing global demand for precision medical and dental tools, driven by an aging population and increasing procedural volumes. Opportunities exist in expanding its product lines with advanced features, enhancing ergonomic designs, and potentially broadening its geographic distribution beyond current channels. The company's established presence since 1999 and its dual distribution model, combining distributors with a direct e-commerce platform, provide a foundation for market penetration. Value drivers are rooted in its specialized product focus and the critical nature of its offerings to professional users. Risks include the company's small scale, intense competition from larger medical device manufacturers, potential regulatory shifts, and the inherent challenges and limited liquidity associated with trading on the OTC Other market. Future performance will depend on its ability to convert its strong gross margin into sustainable profitability and effectively capitalize on market demand for high-quality visualization instruments.
Based on FMP financials and quantitative analysis
SVSO Key Highlights
Gross Margin of 62.2% indicates efficient cost management relative to product sales.
- Profit Margin of -2.0% signals current operational unprofitability.
- Market Capitalization of $0.00B reflects a micro-cap company with limited scale.
- Operates with a focused team of 14 employees, indicating a lean operational structure.
- Founded in 1999, demonstrating over two decades of experience in specialized medical instruments.
Who Are SVSO's Competitors?
SVSO is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| GCTK GlucoTrack, Inc. | $1.21 | -14.18% | — | |
| LUCY Innovative Eyewear, Inc. | $0.89 | -3.14% | $5.62M | — |
| FEMY Femasys Inc. | $2.09 | +1.95% | $6.31M | — |
| RGNT Regentis Biomaterials Ltd. | $1.73 | -6.41% | $12.2M | — |
| MLSS Milestone Scientific Inc. | $0.39 | +1.85% | $34.1M | — |
| NEPH Nephros, Inc. | $3.67 | +0.00% | $39.8M | — |
| POCI Precision Optics Corporation, Inc. | $4.45 | -0.22% | $48.7M | — |
| MBOT Microbot Medical Inc. | $1.16 | -3.33% | $52.9M | — |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are SVSO's Key Strengths?
Specialized niche market focus with established product lines.
- Strong gross margin of 62.2% indicating efficient cost of goods management.
- Dual distribution model leveraging both distributors and an e-commerce platform.
- Long-standing presence since 1999, suggesting experience and market familiarity.
What Are SVSO's Weaknesses?
Small scale with only 14 employees and a $0.00B market capitalization.
- Negative profit margin of -2.0%, indicating current operational unprofitability.
- Reliance on third-party distributors for a significant portion of sales.
- Limited financial transparency and liquidity due to OTC Other tier listing.
What Are the Key Risks for SVSO?
Financial-distress signal — its Altman Z-Score of -8.11 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Intense competition from larger, more diversified medical device manufacturers with greater resources.
- Regulatory changes in the medical device industry impacting product development, approval, or distribution.
- Supply chain disruptions affecting the availability and cost of specialized components for manufacturing.
- Limited financial transparency and liquidity associated with OTC Other tier trading, posing valuation and exit challenges.
- Negative profit margin of -2.0% indicates persistent operational losses, requiring effective cost management and revenue growth to achieve profitability.
What Are SVSO's Competitive Advantages?
- Specialized product focus and expertise in loupe and headlight systems for niche medical markets.
- Established brand presence since 1999, fostering recognition among professional users.
- Proprietary designs and manufacturing capabilities for optical and illumination products.
- Dual distribution strategy combining established distributors with a direct e-commerce channel.
- Commitment to ergonomic design and optical clarity, addressing specific professional needs.
What Does SVSO Do?
SheerVision, Inc., established in 1999 and headquartered in Rolling Hills Estates, California, has carved a niche as a specialized designer, developer, and manufacturer of advanced loupe and headlight systems. These precision visualization tools are indispensable for professionals across various demanding fields, including surgical, dental, dental hygiene, and veterinary markets, where enhanced visual acuity and illumination are paramount for intricate procedures. The company's product portfolio is meticulously engineered to provide ergonomic comfort, superior optical clarity, and robust illumination. Key offerings include a diverse range of flip-up and through-the-lens loupes, which are customized to individual user specifications, ensuring optimal magnification and field of view. These loupes are designed to reduce eye strain and improve posture during prolonged use, a critical factor for practitioners performing detailed work. Beyond magnification, SheerVision also produces specialized headlight systems such as the V-RAY, infinity ultra2, and ultra mini surgical headlights, alongside dedicated dental headlights. These illumination solutions are engineered to deliver focused, shadow-free light directly onto the operative field, significantly improving visibility and precision during delicate operations, examinations, and restorative procedures. The integration of high-quality optics and advanced LED technology in these systems reflects the company's commitment to innovation within its specialized segment. SheerVision's market penetration strategy is built upon a dual distribution model. The company leverages a network of established distributors, which facilitates broader reach into professional healthcare and veterinary practices both domestically and potentially internationally. This channel allows for specialized sales support and local inventory. Complementing this, SheerVision maintains a robust e-commerce website, enabling direct sales to individual practitioners and institutions. This direct-to-customer approach provides convenience, potentially higher margins, and direct feedback channels. With a focused workforce of 14 employees, SheerVision emphasizes deep expertise in its niche, aiming to deliver high-quality, purpose-built instruments that meet the rigorous demands of its professional clientele, thereby supporting precision and efficiency in critical medical and dental procedures. The company's long-standing presence since 1999 underscores its deep-rooted experience and commitment to the specialized medical instruments sector.
What Products and Services Does SVSO Offer?
- Designs and develops specialized loupe systems for enhanced magnification.
- Manufactures various headlight systems for focused illumination during procedures.
- Produces flip-up and through-the-lens loupes tailored for professional use.
- Offers V-RAY, infinity ultra2, and ultra mini surgical headlights.
- Provides dedicated dental headlights for dental and dental hygiene professionals.
- Serves surgical, dental, dental hygiene, and veterinary markets.
- Distributes products through a network of specialized distributors.
- Operates an e-commerce website for direct sales to professionals.
How Does SVSO Make Money?
- Develops and manufactures specialized medical instruments, focusing on optical and illumination tools.
- Generates revenue through the sale of loupe and headlight systems.
- Utilizes a hybrid distribution model, combining third-party distributors for broad market reach.
- Maintains an e-commerce platform for direct-to-professional sales, potentially offering higher margins.
- Targets professional end-users in surgical, dental, and veterinary fields who require precision tools.
What Industry Does SVSO Operate In?
SheerVision, Inc. operates within the dynamic Healthcare sector, specifically in the Medical - Instruments & Supplies industry, a segment characterized by continuous innovation and stringent regulatory requirements. The company's niche focus on surgical, dental, and veterinary loupe and headlight systems positions it within a specialized sub-segment driven by the increasing demand for precision and enhanced visualization in medical procedures. Market trends, such as an aging global population, advancements in minimally invasive surgery, and a growing emphasis on ergonomic tools for practitioners, contribute to sustained demand for such instruments. The competitive landscape includes both larger, diversified medical device manufacturers and other specialized optics companies. SheerVision differentiates itself through its dedicated product lines and established presence since 1999, catering to the specific needs of its professional clientele, but faces competition in terms of technology, pricing, and distribution reach.
Who Are SVSO's Key Customers?
- Surgeons across various medical specialties requiring enhanced visualization.
- Dentists and dental hygienists performing intricate oral procedures.
- Veterinarians and animal hospitals needing precision tools for animal care.
- Medical and dental equipment distributors serving professional practices.
- Individual healthcare professionals purchasing directly through e-commerce.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Financial Health
SheerVision, Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -8.11 places it in the distress zone, a signal of elevated financial risk.
Key Financial Metrics
Return on assets is -16.6%, showing how much profit it generates from its asset base. A current ratio of 0.41 means current liabilities exceed short-term assets, a liquidity point worth watching.
Company Profile
SheerVision, Inc. operates in the Medical - Instruments & Supplies industry within the Healthcare sector. It is headquartered in Rolling Hills Estates, US. The company is led by CEO Suzanne Lewsadder. SVSO has traded publicly since 1995.
SVSO Financials
SVSO Latest News
No recent news available for SVSO.
SVSO Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for SVSO.
Price Targets
Wall Street price target analysis for SVSO.
SVSO MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for SVSO; grades run from A+ (80-100) to F (below 30).
Leadership: Suzanne Lewsadder
CEO
Suzanne Lewsadder serves as the Chief Executive Officer of SheerVision, Inc., where she is responsible for managing the company's operations and strategic direction. Her role involves guiding the design, development, manufacturing, and distribution of SheerVision's specialized loupe and headlight systems for the surgical, dental, and veterinary markets.
Track Record: Specific achievements, strategic decisions, or company milestones directly attributable to Suzanne Lewsadder's leadership are not detailed in the provided source data. Her tenure involves managing the company's day-to-day operations and overseeing its core business functions, including product development, manufacturing processes, and the dual distribution strategy through both distributors and the e-commerce platform.
SVSO OTC Market Information
SheerVision, Inc. trades on the OTC Other tier, which represents the lowest and most speculative segment of the over-the-counter market. Unlike companies listed on major exchanges such as the NYSE or NASDAQ, firms on the OTC Other tier are not required to meet minimum financial standards, such as asset size, shareholder equity, or public float. This tier typically includes companies with limited public information, making it challenging for investors to conduct thorough due diligence. Trading in this tier is often characterized by lower transparency and higher risk compared to regulated exchanges.
- OTC Tier: OTC Other
- Lack of transparent and timely financial disclosures due to "Unknown" disclosure status.
- Extremely low trading volume and liquidity, leading to wide bid-ask spreads and price volatility.
- Absence of minimum financial standards required for listing on the OTC Other tier.
- Increased susceptibility to market manipulation and difficulty in accurate valuation.
- Limited access to capital markets for financing growth compared to exchange-listed companies.
- Verify any available financial statements or reports directly from the company or third-party sources.
- Research management team background and track record beyond provided data.
- Scrutinize business operations, product offerings, and market positioning for viability.
- Investigate any legal filings, corporate actions, or news releases related to the company.
- Assess the company's share structure, outstanding shares, and potential dilution risks.
- Evaluate the actual demand for the company's products in its target markets.
- Consider the long-term sustainability of the business model given its current profitability.
- Established founding year of 1999, indicating a long operational history.
- Clear description of specialized products (loupe and headlight systems) for specific markets.
- Physical headquarters located in Rolling Hills Estates, California, suggesting a tangible presence.
- Identified CEO, Suzanne Lewsadder, managing a team of 14 employees.
- Dual distribution strategy involving both distributors and an e-commerce website.
What Investors Ask About SheerVision, Inc. (SVSO) — Healthcare
What are the financial implications of SheerVision, Inc.'s current profitability and market capitalization?
SheerVision, Inc. exhibits a robust gross margin of 62.2%, indicating strong control over its cost of goods sold relative to its revenue. This suggests that the company's specialized products command a healthy markup.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Beta value of -28.34 is highly unusual and may indicate extremely low trading volume or data anomaly, making it unreliable for standard risk assessment.